Study · Animal study (in vivo) · mouse · 2024
6 resultsLiang J, Zhou C, Zhang C, Liang S, Zhou Z, Zhou Z, Wu C, Zhao H, Meng X, Zou F, Yu C, Cai S
International immunopharmacology7 Dec 2023Cited by 12 (Europe PMC)
The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)
Text rights: Publisher copyright. Results still quote short attributed sentences.
5 results from studies that gave the peptide. No result from this study comes from people.
In asthmatic mice, NMN alleviated airway inflammation.
In plain wordsIn mice with dust mite-induced asthma, NMN reduced airway inflammation.
mousen: not reported in source
HDM-induced asthmaSource sentences
In this research, NMN alleviated airway inflammation and reduced mucus secretion in house dust mite (HDM)-induced asthmatic mice.
In asthmatic mice, NMN reduced mucus secretion.
In plain wordsIn mice with dust mite-induced asthma, NMN reduced mucus secretion.
mousen: not reported in source
HDM-induced asthmaSource sentences
In this research, NMN alleviated airway inflammation and reduced mucus secretion in house dust mite (HDM)-induced asthmatic mice.
In the in vivo HDM asthma model, NMN mitigated airway epithelial barrier disruption.
In plain wordsIn mice with dust mite-induced asthma, NMN reduced airway barrier damage.
mousen: not reported in source
HDM-induced asthmaSource sentences
It also mitigated airway epithelial barrier disruption in HDM-induced asthma in vitro and in vivo.
In this research, NMN alleviated airway inflammation and reduced mucus secretion in house dust mite (HDM)-induced asthmatic mice.
In HDM-induced models, NMN reversed the decrease in SENP1 expression.
In plain wordsIn animal and cell dust mite models, NMN reversed the decrease in SENP1 expression.
n: not reported in source
Source sentences
And down-regulation of SENP1 expression in HDM-induced models was reversed by NMN.
In the in vitro HDM asthma model, NMN mitigated airway epithelial barrier disruption.
In plain wordsIn lab tests with a dust mite asthma model, NMN reduced airway barrier damage.
n: not reported in source
In vitro HDM-induced asthma modelSource sentences
It also mitigated airway epithelial barrier disruption in HDM-induced asthma in vitro and in vivo.
In this study, NMN (nicotinamide mononucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking NMN (nicotinamide mononucleotide).
In HDM-induced asthma models, inhibition of SIRT3 expression abolished NMN effects.
In plain wordsIn animal and cell asthma models, inhibiting SIRT3 expression removed NMN effects.
n: not reported in source
Source sentences
But inhibition of SIRT3 expression abolished the effects of NMN.
It also mitigated airway epithelial barrier disruption in HDM-induced asthma in vitro and in vivo.
In this study, NMN (nicotinamide mononucleotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking NMN (nicotinamide mononucleotide).
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.
Version 2Current
21 Oct 2026, 15:58 UTC
Study results updated
Version 1
21 Oct 2026, 12:50 UTC
First added · source update from Europe PMC
Terms as the source lists them.
PepBank is a research reference. Talk to a doctor before you use any peptide.
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated